A study to see the effects of honey to decrease high fever occurs because of drugs use to treat excess cell growth in suitable patients.
Not Applicable
Recruiting
- Conditions
- Health Condition 1: C760- Malignant neoplasm of head, face and neckHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
- Registration Number
- CTRI/2022/10/046262
- Lead Sponsor
- ot applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Patients with head and neck cancer undergoing neo-adjuvant chemotherapy
2 Age greater than 18 years
3 Patients who are willing to participate in the study and one fit for DCF or DC
The Objective criteria as fit for DCF or DC will be as follows
A ECOG Performance scale 02
B Normal organ function test values
a Creatinine clearance greater than equal to 30ml per min
b SGPT or SGOT less than equal to 3.5ULN
c Hemoglobin greater than 8 gm
d ANC equal to 1000
e Platelet equal to 1 lakh
Exclusion Criteria
1 Patients with any other site solid tumor.
2 Patients with hematolymphoid cancer.
3 All patients with diabetic mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?? To assess the efficacy of honey in reducing chemotherapy induced grade 3 or worse febrile neutropenia.Timepoint: 34 DAYS
- Secondary Outcome Measures
Name Time Method â?? Clinical data would be analysed to Grade anemia, thrombocytopenia and neutropenia. <br/ ><br>â?? Incidence of febrile neutropenia would be reported in counts and percentages. <br/ ><br>â?? The factors including duration of hospitalization and number of episodes of hospitalization) influenced by febrile neutropenia would be analyzedTimepoint: 34 DYAS